Trilostane 10 mg Oral Capsules are a solid dosage form consisting of two halves of either gelatin or vegetarian-based shells that encapsulate the precise 10 mg dose of the active ingredient, trilostane. These capsules are designed for ease of oral administration and are intended for patients who require this specific dosage strength. Trilostane is used in the treatment of Cushing's syndrome (hypercortisolism) and may also be prescribed for the management of adrenal gland tumors (adrenocortical carcinoma) and for the treatment of alopecia or hirsutism associated with hyperandrogenism. The encapsulated form ensures accurate dosing and patient convenience.
Trilostane 10 mg Oral Capsules are a solid dosage form consisting of two halves of either gelatin or vegetarian-based shells that encapsulate the active pharmaceutical ingredient, trilostane. These capsules are designed to be easily swallowed, ensuring patient compliance and comfort. The encapsulation of trilostane in this manner provides a precise dosage, which is critical for the efficacy and safety of the medication. Trilostane is specifically used in the treatment of endocrine disorders such as Cushing's syndrome (hypercortisolism) and Addison's disease (hypoadrenocorticism) in certain cases.
In the management of Cushing's syndrome, trilostane works by inhibiting the enzyme 3β-hydroxysteroid dehydrogenase, which is involved in the biosynthesis of glucocorticoids, mineralocorticoids, and sex steroids. By inhibiting this enzyme, trilostane reduces the excessive production of cortisol, thereby alleviating the symptoms associated with Cushing's syndrome, such as increased thirst and urination, increased appetite, hair loss, and a pot-bellied appearance. It is important to note that trilostane does not cure Cushing's syndrome but helps to manage the symptoms.
For Addison's disease, trilostane may be used in cases where there is a need to temporarily suppress adrenal function as part of a diagnostic process or when other treatments are not suitable. However, its use in Addison's disease is less common and should be approached with caution, as the disease typically involves a deficiency in cortisol production.
Prescribers should be aware that the dosing of trilostane requires careful titration and monitoring of the patient's hormone levels to avoid potential side effects, such as adrenal insufficiency or an overdose of the medication. Regular follow-up and adjustment of the dosage may be necessary to ensure optimal treatment outcomes. Patients should be counseled on the importance of adhering to their prescribed dosing schedule and to report any side effects or symptoms of concern to their healthcare provider promptly.
Bayview Pharmacy is committed to providing high-quality compounded medications tailored to the needs of individual patients. Our team of compounding pharmacists is available to answer any questions and provide additional information regarding trilostane 10 mg Oral Capsules or other compounded medications. If you have any questions or require further assistance, please do not hesitate to reach out to us.
Trilostane is an adrenostatic agent used primarily to treat Cushing's syndrome (hypercortisolism) and, less commonly, for the treatment of aldosterone-producing adrenal tumors. It works by inhibiting the enzyme 3β-hydroxysteroid dehydrogenase, which is involved in the biosynthesis of several steroids, including cortisol. When prescribing trilostane, it is crucial to consider potential drug interactions that may affect its efficacy and safety.
Trilostane can interact with other medications that affect steroid synthesis or action. For example, concurrent use with other adrenocortical suppressants (e.g., ketoconazole, metyrapone) may increase the risk of adrenal insufficiency. Patients should be monitored closely for signs of adrenal insufficiency, such as fatigue, nausea, and hypotension, and the dosage of trilostane may need to be adjusted accordingly.
Medications that induce or inhibit hepatic enzymes, particularly cytochrome P450 enzymes, may alter the metabolism of trilostane. Strong CYP3A4 inducers, such as rifampicin and phenytoin, may decrease trilostane levels, potentially reducing its effectiveness. Conversely, CYP3A4 inhibitors like ketoconazole, itraconazole, and ritonavir may increase trilostane levels, raising the risk of adverse effects. Careful monitoring and dose adjustments may be necessary when trilostane is co-administered with these agents.
Trilostane may also interact with drugs that have a narrow therapeutic index and are metabolized by CYP3A4, such as certain calcium channel blockers, immunosuppressants, and anticoagulants. For instance, the anticoagulant effect of warfarin may be altered when used with trilostane, necessitating close monitoring of INR and potential dose adjustments of the anticoagulant.
Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) used concurrently with trilostane may increase the risk of hyperkalemia. Patients should have their serum potassium levels monitored regularly, and the use of potassium-sparing diuretics should be approached with caution.
Patients receiving trilostane should avoid using over-the-counter medications, herbal supplements, or other prescription drugs without first consulting their healthcare provider, as many substances may interact with trilostane. For example, certain herbal supplements like licorice may potentiate the effects of trilostane and should be used with caution.
It is also important to note that trilostane can cause adrenal insufficiency, which may be exacerbated by other medications that lower cortisol levels or increase cortisol metabolism. Patients should be educated on the signs and symptoms of adrenal insufficiency and instructed to seek medical attention if they experience these symptoms.
Lastly, trilostane may affect glucose metabolism, and caution is advised when used in diabetic patients, as it may necessitate adjustments in antidiabetic medication dosages. Regular monitoring of blood glucose levels is recommended for patients on trilostane who are also receiving antidiabetic therapy.
In summary, trilostane has the potential to interact with a wide range of medications, and careful consideration and monitoring are required when it is prescribed in combination with other drugs. If you have any questions or require further information regarding drug interactions with trilostane, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe and effective use of trilostane oral capsules.
Trilostane 10 mg Oral Capsules are a solid dosage form designed to treat conditions such as Cushing's syndrome and Addison's disease in humans, and Cushing's disease (hyperadrenocorticism) in dogs. These capsules consist of two halves, either made from gelatin or a vegetarian substitute, which are filled with the precise amount of trilostane, the active ingredient. The capsule shells are easily swallowed and dissolve in the digestive system to release trilostane for absorption.
Trilostane works by inhibiting an enzyme known as 3β-hydroxysteroid dehydrogenase, which is involved in the production of several steroids, including cortisol. By inhibiting this enzyme, trilostane reduces the synthesis of cortisol in the adrenal glands. Cortisol is a hormone that plays a vital role in the body's response to stress and in the metabolism of proteins, carbohydrates, and fats. In conditions like Cushing's syndrome, the body produces too much cortisol, leading to a variety of symptoms such as weight gain, high blood pressure, and skin changes. By controlling cortisol production, trilostane helps alleviate these symptoms.
In the treatment of Addison's disease, trilostane is used in a different way. Addison's disease is characterized by insufficient production of adrenal hormones, including cortisol. Trilostane is used in what's known as the 'block and replace' regimen, where it blocks the production of adrenal hormones, and then the patient is given a replacement dose of glucocorticoids and mineralocorticoids to maintain proper hormone levels.
It is important for patients and prescribers to understand that the effectiveness of trilostane can vary based on the individual's absorption rate, the severity of the disease, and other medications the patient may be taking. Regular monitoring of adrenal function and adjusting the dosage accordingly is crucial for the safe and effective use of trilostane capsules. Additionally, patients should be aware of potential side effects, which can include gastrointestinal disturbances, fatigue, and in some cases, adrenal insufficiency.
For those interested in using Trilostane 10 mg Oral Capsules, it is essential to have a thorough understanding of the disease state being treated and to engage in regular monitoring and consultation with a healthcare provider. If you have any questions or require further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing you with the knowledge and support necessary to manage your health condition effectively.
Trilostane 10 mg oral capsules are traditionally prescribed for the management of Cushing's syndrome, which is characterized by overproduction of cortisol by the adrenal glands, and for the treatment of certain forms of adrenal gland cancer. As a compounding pharmacy, we understand that medications may often have additional clinical applications beyond their primary indications.
Besides the well-known uses in treating Cushing's syndrome in humans, trilostane can also be used in veterinary medicine. It is commonly prescribed by veterinarians for the treatment of hyperadrenocorticism (Cushing's disease) in dogs. The mechanism of action, which involves reversible inhibition of 3β-hydroxysteroid dehydrogenase, helps to reduce the excessive production of cortisol in animals similarly to its effects in humans. It is important for veterinarians and pet owners to work closely with a compounding pharmacy to obtain the appropriate dosing in a form that is suitable for animal administration.
Another potential off-label use of trilostane that is being investigated is for the treatment of alopecia in females. This condition may sometimes be associated with elevated androgen levels and preliminary research suggests that trilostane could help manage this condition by inhibiting adrenal steroidogenesis. However, more research is needed to establish its efficacy and safety for this particular use.
While considering the use of trilostane for indications other than those approved, it is crucial for prescribers to weigh the benefits against the potential risks and to be guided by contemporary research and clinical judgments. Compounded trilostane should be used under a healthcare provider's supervision with appropriate monitoring, due to the significant effects it can have on the hormone balance within the body.
Patients and prescribers interested in exploring alternative applications of trilostane are encouraged to reach out to us here at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is equipped to provide additional information on the potential uses of trilostane and to partner with healthcare providers in creating individualized treatment regimens that are tailored to the specific needs of patients or veterinary clients.
Trilostane 10 mg Oral Capsule is a prescription medication used to treat conditions such as Cushing's syndrome and Addison's disease in dogs. The active ingredient, Trilostane, helps to inhibit the production of certain steroids in the adrenal glands, providing relief from the symptoms associated with these conditions.
Trilostane 10 mg Oral Capsules should be stored at room temperature, away from light and moisture. Keep the capsules in their original container, and make sure the lid is tightly sealed to protect the medication from environmental factors.
The capsule shells for Trilostane 10 mg Oral Capsules are made of either gelatin or a vegetarian alternative, which encloses the medication and allows for easy swallowing.
It is not recommended to open the Trilostane 10 mg Oral Capsules as they are designed for precise dosing. Please consult your veterinarian before making any changes to the medication's form.
The dosing frequency of Trilostane 10 mg Oral Capsules should be determined by your veterinarian, based on your pet's specific condition and response to treatment.
If you miss a dose of Trilostane 10 mg Oral Capsule, administer it as soon as possible. However, if it is almost time for the next scheduled dose, skip the missed dose and resume your pet’s regular dosing schedule. Do not double up on doses.
As with any medication, there can be potential side effects. Common side effects of Trilostane include, but are not limited to, vomiting, lethargy, and reduced appetite. If you observe any concerning symptoms, contact your veterinarian immediately.
No, Trilostane 10 mg Oral Capsules are specifically formulated for veterinary use. Human consumption is not safe and can lead to adverse effects or drug interactions.
Trilostane works by inhibiting the enzyme 3β-hydroxysteroid dehydrogenase, which is involved in the synthesis of glucocorticoids and mineralocorticoids. This inhibition reduces the excessive production of cortisol, which is typically seen in Cushing's syndrome.
Before starting treatment with Trilostane 10 mg Oral Capsules, discuss your pet's current health status, any other medications or supplements they are taking, and any allergies or pre-existing conditions. It's also important to understand the follow-up schedule and what monitoring is necessary for your pet's safety and well-being.